Results 71 to 80 of about 19,437 (169)

Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study

Journal of Experimental & Clinical Cancer Research, 2009
Background Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched ...
Müller Christian, Peck-Radosavljevic Markus, Kettenbach Joachim, Schöniger-Hekele Maximilian   +3 more
doaj   +1 more source

Prolonged Octreotide Therapy in a Neonate with Recurrent Congenital Chylothorax

Indian Pediatrics Case Reports
Background: Congenital chylothorax (CC) is the most common cause of pleural effusion in neonates. While octreotide is a known therapy for this condition, refractory cases usually require high doses of the drug or surgical intervention.
Madhurima Ganguly, Sk Md Habibullah, Bijan Saha   +2 more
doaj   +1 more source

OCTREOTIDE IN GASTROENTEROLOGY [PDF]

Medical Journal Armed Forces India, 1997
R, Chaudhry, Balwinder, Singh, P, Subhas
openaire   +2 more sources

Differential Effects of Somatostatin on TNF Receptors and Apoptosis in Hepatocellular Carcinoma Cell Lines

Gastroenterology Insights
The anti-tumoral activity of somatostatin has been demonstrated in both animal experiments and human tumors. Clinical trials have reported conflicting results.
Maria Georgiadou, George Notas, Ioannis Tsomidis, Argyro Voumbouraki, Ioannis Drygiannakis, George Emmanouil, Elias Kouroumalis   +6 more
doaj   +1 more source

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor

Case Reports in Hematology, 2013
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding.
Kocfa Chung-Delgado, Alejandro Revilla-Montag, Sonia Guillén-Bravo, Hugo Ríos-Díaz, José C. Alva-Muñoz   +4 more
doaj   +1 more source

18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports

Frontiers in Endocrinology
ObjectiveThis study aims to report the application of 18F-AlF-NOTA-Octreotide PET/CT and 3D printing technology in the diagnosis and treatment of phosphaturic mesenchymal tumors (PMT) in patients with tumor-induced osteomalacia (TIO).Case presentationA ...
Gang Zhao, Lijuan Guan, Yongqiang Zhang, Xingzhen Shi, Wenming Luo, Maiqing Yang, Qi Wang, Zhen Liu, Yongqiang Liu, Xiaolei Ding, Jie Zhao   +10 more
doaj   +1 more source

Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice

Heliyon
Background: Patients with high-risk neuroblastoma (NB) have a 5-year event-free survival of less than 50 %, and novel and improved treatment options are needed. Radiolabeled somatostatin analogs (SSTAs) could be a treatment option.
A. Romiani, K. Simonsson, D. Pettersson, A. Al-Awar, N. Rassol, H. Bakr, D.E. Lind, G. Umapathy, J. Spetz, R.H. Palmer, B. Hallberg, K. Helou, E. Forssell-Aronsson   +12 more
doaj   +1 more source

Peculiarities of acute myocardial infarction course and distribution of the somatostatin receptor analogue 99mTc-octreotide in the heart

Российский кардиологический журнал
Aim. To study the relationship between the clinical course of myocardial infarction (MI) with changes in left ventricular (LV) geometry and myocardial accumulation of the somatostatin analogue 99mTc-octreotide according to cardiac single-photon emission ...
V. V. Ryabov, A. G. Syrkina, A. A. Trusov, A. I. Mishkina, S. I. Sazonova, Yu. N. Ilyushenkova   +5 more
doaj   +1 more source

Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions. [PDF]

Int J Mol Sci
Periferakis A, Troumpata L, Xefteris I, Mavrokefalos AK, Periferakis AT, Periferakis K, Caruntu A, Scheau AE, Dragosloveanu CDM, Caruntu C, Scheau C.   +10 more
europepmc   +1 more source

Amanita Species Mushroom Poisonings - Northern California, November 2025-March 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Brandecker KJ, Hayman C, LeSaint KT, Vohra R, Choudhury A, Marder ME, Bartlett R, Barreau T, Smollin CG.   +8 more
europepmc   +1 more source